Abstract:Background Nasopharyngeal carcinoma (NPC) is a distinct subtype of head and neck cancer which is prevalent in south of China and southeastern of Asia. Consistent activation of interferon (IFN) signaling, and impairment of T cell mediated antitumor immunity is frequent in NPC. Forkhead box A1 (FOXA1) is one of the earliest discovered pioneer factors, which can open up compact chromatin structures to facilitate the binding of other proteins to chromatin.Methods By using RNA sequencing, it was discovered that FOXA1 suppresses the activation of the interferon signaling pathway and the expression of the related interferon-responsive genes in NPC cells. The effect of FOXA1 on programmed death-ligand 1 (PD-L1) expression in C666-1 and HK1 cells under conditions with or without IFN-γ was detected through quantitative PCR (qPCR), western blot, and flow cytometry. After co-culturing T cells with IFN-γ-treated NPC cells in vitro, apoptosis of CD8+ T cells and the expression of cytotoxic cytokines were assessed by flow cytometry. The cytotoxic effects of T cells on tumor cells in nude mice were measured by tumorigenesis in nude mice and adoptive T cell therapy. The effects of IFN-γ on the expression and nuclear localization of STAT1, as well as the colocalization of FOXA1 with STAT1 were detected by immunofluorescence, qPCR, western blot, and co-immunoprecipitation experiments.Results In this study, we reported that loss of FOXA1, a pioneer factor downregulated in NPC, results in activation of IFN signaling in NPC cells. Repression of FOXA1 facilitates IFN-γ induced PD-L1 expression, whereas overexpression of FOXA1 exerts the opposite effect. Mechanistically, FOXA1 interacts with STAT1 and inhibits IRF1 expression and binding to PD-L1 promoter on IFN-γ treatment. Co-culture with FOXA1-silenced NPC cells promotes apoptosis of in vitro activated tumor-specific CD8+T cells and reduces the expression of cytotoxic effector molecules. Furthermore, overexpression of FOXA1 increases the therapeutic efficacy of PD-L1 antibody (atezolizumab) against NPC in nude mice receiving adoptive T-cell therapy.Conclusions We demonstrated that FOXA1 prevents tumor immune evasion by inhibiting IFN-γ induced PD-L1 expression in NPC cells. Our research findings provide new insights into the immunotherapeutic biomarkers and targets for NPC, which is important for the clinical application of programmed cell death protein-1/PD-L1 antibodies in NPC.

Long Non-Coding RNA FOXD1-AS1 Promotes the Progression and Glycolysis of Nasopharyngeal Carcinoma by Sustaining FOXD1 Expression.

Long Non-Coding RNA GNAS-AS1 Promotes Cell Migration and Invasion Via Regulating Wnt/β-catenin Pathway in Nasopharyngeal Carcinoma.

Long Non-Coding RNA FOXD2-AS1 Aggravates Nasopharyngeal Carcinoma Carcinogenesis by Modulating Mir-363-5p/s100a1 Pathway.

LncRNA FOXD3-AS1 Promotes the Malignant Progression of Nasopharyngeal Carcinoma Through Enhancing the Transcription of YBX1 by H3K27Ac Modification

LncRNA HOXC-AS1 Promotes Nasopharyngeal Carcinoma (NPC) Progression by Sponging Mir-4651 and Subsequently Upregulating FOXO6.

Long non-coding RNA FOXP4-AS1 acts as an adverse prognostic factor and regulates proliferation and apoptosis in nasopharyngeal carcinoma

Long noncoding RNA LINC00930 promotes PFKFB3-mediated tumor glycolysis and cell proliferation in nasopharyngeal carcinoma

Upregulated Long Non-Coding Rna Afap1-As1 Expression is Associated with Progression and Poor Prognosis of Nasopharyngeal Carcinoma

FOXM1 Regulates Glycolysis in Nasopharyngeal Carcinoma Cells Through PDK1.

High Expression of LINC01420 Indicates an Unfavorable Prognosis and Modulates Cell Migration and Invasion in Nasopharyngeal Carcinoma

LINC00173 Facilitates Tumor Progression by Stimulating RAB1B‐mediated PA2G4 and SDF4 Secretion in Nasopharyngeal Carcinoma

Long Non-Coding RNA LINC01133 Mediates Nasopharyngeal Carcinoma Tumorigenesis by Binding to YBX1.

Long Non-Coding RNA DANCR Stabilizes HIF-1 Alpha and Promotes Metastasis by Interacting with NF90/NF45 Complex in Nasopharyngeal Carcinoma

FOXG1 improves mitochondrial function and promotes the progression of nasopharyngeal carcinoma

FOXA1 Reprograms the TGF-β-stimulated Transcriptional Program from a Metastasis Promoter to a Tumor Suppressor in Nasopharyngeal Carcinoma.

Long Non‑coding RNA DANCR Promotes Nasopharyngeal Carcinoma Cell Proliferation and Migration.

FOXA1 Enhances Antitumor Immunity Via Repressing Interferon-Induced PD-L1 Expression in Nasopharyngeal Carcinoma

LncRNA FOXD1-AS1 acts as a potential oncogenic biomarker in glioma.

Long Noncoding RNA ZFAS1 Promotes Tumorigenesis and Metastasis in Nasopharyngeal Carcinoma by Sponging Mir‐892b to Up‐regulate LPAR1 Expression

m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinoma

LncRNA FOXP4-AS1 Silencing Inhibits Metastasis and Epithelial–mesenchymal Transition in Nasopharyngeal Carcinoma Via Mir-136-5p/mapk1